Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3739366012 | Cromolyn and xylometazoline only product in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739367015 | Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739368013 | Cromoglicic acid and xylometazoline only product in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | Is a | Product containing only cromoglicic acid and xylometazoline (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | Has active ingredient | Cromoglicic acid | true | Inferred relationship | Some | 1 | |
| Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | Has manufactured dose form | Nasal dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | Has active ingredient | Xylometazoline (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | Is a | Product containing cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Is a | True | Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR